knowledge -WSS

knowledge

author：explore 2025-09-06 02:01:52 - browse：3336

SAN DIEGO — Months after announcing plans to cut costs by $100 million, DNA sequencing giant Illumina has begun to lay off 10% of its research and development team, according to internal emails obtained and reviewed by STAT.

The layoffs, which began last Wednesday, impact research teams across the company’s California sites in San Diego and Foster City, as well as locations in Madison, Wisconsin; Singapore; and the United Kingdom. Alex Aravanis, the company’s chief technology officer, noted in an internal message that these cuts affect a tenth of research and development staff. The company’s also planning to shut down all lab-based research and development work in Foster City, according to a note from Steve Barnard, vice president of technology development.

Barnard’s note mentions that all affected employees have already been notified. And a separate message from interim CEO Charles Dadswell makes clear last week’s layoffs won’t be the last.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Alkermes shareholders re
Next article： Readout Newsletter: BridgeBio, Akero, and human embryo models

hotspot

WSS

FDA seeks to regulate lab

Stem cell biologist probes earliest stages of human development

Medicare drug price negotiation continues, as pharma counteroffers

Medicare drug price negotiation hearing pits pharma v Biden admin

IVF doctors demand details after CooperSurgical lawsuit

Florida health officials providing scant details on measles cases

Wikipedia

knowledge

knowledge

Medical leaders decry Supreme Court decision on affirmative action

Sudafed saga points to U.S. issues with evaluating older drugs

Activists slam private health insurers over coverage restrictions

IVF doctors demand details after CooperSurgical lawsuit

Duchenne breakthrough therapy leaves behind pioneering families

He's 19 months old and has one of the world’s rarest diseases

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

FDA advisers vote against ALS treatment from BrainStorm

Medicare details structure of new drug price negotiation program

Readout Newsletter: BridgeBio, Akero, and human embryo models

hotspot

Why do women spend more than men on medical expenses?

Medicare drug price negotiation program allowed for now

Immune cells and nerve overgrowth may explain recurring UTI pain

Listen: Who gets the credit for GLP

Why Talkspace is targeting Medicare, a tricky market

Readout Newsletter: The latest on Novo Nordisk, Alnylam, Apogee

leisure time

hotspot

explore

focus